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Hypocaloric Total Parenteral Nutrition: 
Effectiveness in Prevention of 
Hyperglycemia and Infectious 
Co m pl ica ti on s-A Randomized 
Clinical Trial 
KC hlcCowen, C Friel, J Sternberg, et a1 
-Beth Israel Deaconess Medical Center and Haruard 
Medical School, Boston 
ABSTRACT: Objective: To determine whether the frequency 
rate of hyperglycemia and infectious complications can be 
reduced by an underfeeding strategy in  patients requiring total 
parentcral nutrition (TI”), without deleterious effects on nitro- 
gen balance. Design: Prospective, randomized, controlled non- 
blinded trial. Setting: A university-affiliated teaching hospital 
with a dedicated TPN service. Patients: TPN was initiated in 40 
adult patients and continued for 5 days. Intervention: T\vo differ- 
ent TI” feeding strategies were compared: hypocaloric feeding (1 
L containing 70 g protein and 1000 kcal) and standard weight- 
based rcgimen, begun in similar amounts initially, but advanced 
in increments towards 25 kcal and 1.5 g proteinkg dry (or 
adjusted ideal) weight. Measurements and Main Zlesults: We 
evaluated the frequency rate of hyperglycemia, average blood 
glucose, numbers and types of infections while receiving nutri- 
tional support, and nitrogen balance after 5 days of TPN. There 
were significant differences between the quantities of calories, 
dextrose, fat, and protein provided to the two groups. However, 
average blood glucose, frequency rate of hyperglycemia, and 
infection rates (from intra-venous catheter, pneumonia, and 
woundhbdominal collection) mere similar in each group. The 
control group showed a trend towards a higher insulin require- 
ment. Nitrogen balance, only available as  a subset, was signifi- 
cantly more negative in the hypocaloric group. Conclusions: 
Provision of TPN to a goal of 25 kcallkg was not associated with 
niore hyperglycemia or infections than a deliberate underfeeding 
strategy. A regimen of 1.5 g k g  protein in conjunction with 25 
kcalkg did, however, provide significant nutritional benefit in 
terms of nitrogen balance in comparison with hypocaloric TI”. 
(Crit Care RIed 28:3606-3611,2000) 
COIhMENT: Hypocaloric high proteirdlow calorie paren- 
tern1 nutrition (I“) has been used in obese patients to 
avoid overfeeding while achieving net protein anabolism. 
This prospective, randomized study compared the  
hypocaloric us standard PN effects on hyperglycemia, 
infection rate, and nitrogen balance. Forty adult patients 
were randomized to receive daily PN for 5 to 10 days as 
either standard (20-25 kcalkg, amino acids 1.5 f i g ,  
lipids up to one-third of total calories) or hypocaloric I“ 
(dextrose 210 g, amino acids 70 6). During the course of 
I”, hyperglycemia was defined as capillary glucose con- 
centrations >220 mg/dL, and infections were defined as 
pneumonia, wound, abdominal, and catheter-related 
infections. Nitrogen balance was estimated by measuring 
urine urea nitrogen. 
Over the study period, fewer daily average calories (14 
us 18 kcal/kg), dextrose (187 5 26 us 225 2 41 g), and 
protein (70 2 0.2 us 89 2 13 g) were provided in the  
hypocaloric than in the control group, respectively. Study 
findings showcd no significant differences between the two 
groups in average blood glucose concentrations, frequency 
of hyperglycemia, or infection rate. Mean nitrogen balance 
was more negative in the hypocaloric group. 
Study limitations include: (1) a small study group tha t  
may not have allowed observing any differences; (2) nitro- 
gen balance that was measured in a subset of patients; (3) 
randomization bias tha t  may have occurred as more 
patients in the hypocaloric group had pancreatitis and 
were on mechanical ventilation than in the control group; 
and (4) lipids that were not part of the hypocaloric regi- 
men, which othenvise might have had additional protein- 
sparing effects and improved nitrogen balance. 
This study failed to show the advantages of hypocaloric 
PN over standard PN on nitrogen balance. Only 8 patients 
i n  this study were reported as obese with a BRZI 230. 
Although in other studies a positive nitrogen balance was 
achieved in obese hospitalized patients who received 
hypocaloric PN, large studies a re  needed to assess the  
safety and efficacy of hypocaloric feeding in non-obese 
patients. Net protein catabolism is difficult to prevent 
during the systemic inflammatory response in stressed 
hospitalized patients. To prevent PN-associated hypergly- 
cemia and its consequences in adult patients, avoid over- 
feeding, provide a balanced source of energy substrates, 
and  limit dextrose infusion ra te  to  5 4  nigkg per minute 
with insulin administration if necessary. 
Imad F. Btaiche, PharmD, BCNSP 
Evaluation of an Antiseptic Triple-lumen 
Catheter in an Intensive Care Unit 
EM Hanley, A Veeder, T Smith, e t  a1 
Department of Epidemiology, Albany hfedical Center 
Hospital, New York 
ABSTRACT: Objecfive: To evaluate a decrease in catheter- 
related bloodstream infection rate in patients with antiseptic 
triple-lumen catheters in an intensive care unit. Data Sources: 
Retrospective review of surveillance records, patient medical 
records, laboratory and microbiological reports, and antibiotic 
administration records. Study Selechm: Patients admitted to the 
intensive care unit with triple-lumen catheters. Data Extraction: 
A subset of one entry per patient was extracted from 2 years of 
primary bloodstream infection surveillance data. Data collection 
included risk factors, laboratory and microbiological data, and 
insertion sites and dates of all intravascular catheters present 
during triple-lumen catheterization. Data Synthesis: The cathe- 
ter-related bloodstream infection rate was 5.4 and 11.3 per 1000 
catheter days in antiseptic and nonantiseptic triple-lumen cath- 
eter groups, respectively (p = .OG). By multivariate analysis using 
a Cox Proportional Hazards hlodel, the antiseptic triple-lumen 
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catheters were associated with a significant reduction in cathe- 
ter-related bloodstream infection (p = .03). RIodel expansion to 
include intrajugular site was significant by a likelihood ratio test 
[2(log likelihood dill3 = 4.26 P < .05 3(1)] Conclirsions: The use 
of antiseptic triple-lumen catheters may substantially reduce 
catheter-related bloodstream infections in an intensive care pop- 
ulation and may be subsequently associated with a decrease in 
length of stay. (Crit Care hIed 28:366-370, 2000) 
:., 
COMMENT: It is est imated that 5 million central  venous 
catheters  (CVCs) are placed yearly i n  pat ients  in the U.S. 
with 2% t o  19% of these pat ients  developing a catheter  
related bloodstream infection (CR-BSI). Approximately 
80,000 CR-BSIs occur i n  ICUs each year i n  the United 
States, increasing pat ient  hospitalizatiodcosts and wi th  
an at t r ibuted mortality ranging from 12% to 25%. 
The authors  of this  well-designed s tudy  report that the 
use of a n  antiseptic (silver sulfadiazindchlorhexidine) 
triple lumen catheter  was  effective at reducing the rate of 
CR-BSI within an ICU pat ient  population, 5.4 per  1000 
catheter  days compared with nonantiseptic triple lumen 
devices, 11.3 per  1000 catheter  days. Whereas  the resul ts  
did not achieve statistical significance ( p  = .06), the s tudy  
clearly indicates that use of antiseptic CVCs decreases the 
risk of nosocomial bloodstream infection i n  the ICU high- 
risk pat ient  population. A secondary finding of the s tudy  
suggests  that a n  antiseptic impregnated CVC m a y  
decrease the risk of CR-BSI at t h e  intrajugular  site, which 
has been traditionally associated wi th  a higher  rate of 
infection than the subclavian site. 
Several s tudies  have  appeared i n  the l i terature  sup-  
porting the use of antiseptic impregnated CVCs in high- 
risk pat ien t  populations. The present  s tudy  found that the 
maximal  benefit derived from use  of an antiseptic impreg- 
nated device occurs between d a y  5 a n d  d a y  14. This  
finding by  the au thors  suggests the importance of identi- 
fying sentinel r isk factors because not  all pat ients  are 
equally at risk for CR-BSI, thereby deriving minimal 
benefit from the use  of this new (expensive) technology. 
Charles E. Edmiston, Jr, PhD, CIC 
Randomised Controlled Trial of Oral 
Vitamin A Supplementation in Preterm 
Infants to Prevent Chronic Lung 
Disease 
SP Wardle, A Hughes, S Chen, et a1 
Liverpool Women’s Ilospital, Liverpool, UK 
ABSTKACT: Background: Intramuscular supplementation 
with vitamin A in large doses may reduce the incidence of chronic 
lung disease. Aim: To investigate whether oral supplementation 
with vitamin A would reduce the incidence of chronic lung disease 
in a group of extremely lorn birthweight infants. Methods: Infants 
with birth weight <lo00 g were randomized a t  birth to receive 
oral vitamin A supplementation (5000 IU/day) or placebo for 28 
days. The primary outcome was oxyien dependency a t  28 days of 
age or death. Results: A total of 154 infants were randomized; 77 
received vitamin A (median birth weight [interquartile range] 
806 1710-8901 g),  and 77 received placebo (median birth weight 
[interquartile range] 782 [662-8801 6). Plasma vitamin A concen- 
trations in the supplemented group were significantly higher a t  
24 hours of age but did not differ significantly a t  birth, 12 hours 
of age, 7 days, or 28 days of life. There were no Significant 
differences in the proportion of infants who survived, required 
oxygen at  28 days, required oxygen a t  36 wecks postnienstrunl 
age, survived without chronic lung disease at  36 weeks, survived 
without significant retinopathy, or who survived without signifi- 
cant intraventricular haeniorrhage. Coriclusious: Oral supple- 
mentation with 5000 IU vitamin A in extremely low birthweight 
infants does not significantly alter the incidence of chronic lung 
disease. IIowver, this dose may have been inadequate to achieve 
optimal serum retinol concentrations. (Arch of Dis Child Fetal 
Neonatal Ed 81:F9-F13, 2001). 
COMMENT: Vitamin A maintains  epithelial cells and 
has an important  role i n  the immune system. Preterni  
infants  have  a propensity t o  develop chronic lung  disease 
and studies  of vi tamin A supplementation i n  pre te rm 
infants  have demonstrated a protective effect. Iloivever, 
a l l  of these s tudies  utilized intramuscular  administration. 
The present s tudy  at tempted to t a k e  a kinder  approach 
and utilize a n  oral  vi tamin A supplement. Unfortunately, 
th i s  s tudy  found no protective effect from t h e  oral vi tamin 
A supplementation. This  is  not surpr is ing as t h e  infants  
given oral vi tamin A did not achieve a sustained increase 
i n  their  circulating retinol levels. The  knowledge to be 
gained from th is  s tudy  is  not t h a t  vi tamin A has no effect 
on  t h e  lungs of premature  infants, b u t  that a n  oral dose of 
5000 IU of vi tamin A i s  inadequate  to  sustain a n  increase 
i n  circulating retinol levels. This  implies t h a t  to  achieve 
an increase i n  vi tamin A levels, e i ther  a larger  oral dose 
must be tested or it m u s t  be  administered systemically. 
Mark R. Corkins, hlD 
Acute Effects of Different Nutritional 
Supplements on Symptoms and 
Functional Capacity in Patients with 
Chronic Obstructive Pulmonary Disease 
MAP Vermeeren, EF Wouters, LH Nelissen, ct nl 
Departments of Pitlrnoriology and Dietetics, University 
Hospit a1 hfanast richt, Maastricht, Net h erlari ds, and 
Numico Research, Wagen ingen, Netherlands 
ABSTRACT: Bochground: Use of nutritional supplements in 
depleted patients with chronic obstructive pulmonary disease 
(COPD) requires optimization between positive effects on out- 
come and potential acute adverse effects on metabolism and 
exercise performance. Objectice: The aim of this study was to 
investigate the acute effects ofnutritional supplements on metab- 
olism and esercise capacity in stable COPD patients. Design: In 
part 1, the effects of 3 different enerby loads (placebo, 1016 kJ, 
and 2092 kJ) with a normal distribution of macronutrients were 
investigated in 14 COPD patients. In part 2, the effects of a 
fat-rich compared with a carbohydrate-rich supplement (both 
1016 kJ) mere studied in 11 COPD patients. The study was 
performed in a randomized, double-blind, crossover fashion. hlet- 
abolic and ventilatory variables were measured postprandially 
and during a submaximal cycle endurance exercise test. Results: 
Overall, no immediate negative effects of the supplements were 
found in part 1. A slight but significant postprandial increase in 
respiratory quotient was found after the 1016-kJ and 2092-kJ 
supplements compared with placebo. There was no significant 
difference in metabolism or exercise capacity after a fat-rich or 
carbohydrate-rich supplement. Surprisingly, the change in short- 
ness of breath (postprandial compared with preprandial) was 
significantly g-reater after the fat-rich supplement. Coriclusiorw 
An energy load up to 2092 k J  had no adverse immediate effect in 
COPD patients compared with placebo. The subjects who con- 
266 CURRENT LITERATURE Vol. 16, No. 4 
sunied the  fat-rich supplenicnt experienced more shortness of 
breath than  did the  subjects who consumed the  carbohydrate-rich 
supplement. (Am J Clin Nut  73: 295-301,2001) 
COMMENT: Epidemiologic studies indicate that the 
prognosis for nialnourished patients with COPD is worse 
than their well-nourished counterparts. The focus of 
nutritional care for patients with COPD is maintenance of 
a n  acceptable weight for height.'., Evidehce of low weight 
for height, despite reported calorie intake of 156% to 162% 
of resting energy expenditure supports the observation of 
increased oxygen (0,) consumption in COPD  patient^.^ 
The researchers in this study examined the  effects of 
nutrient dense supplements us standard caloric supple- 
ment and high fat us high carbohydrate (CHO) supple- 
ment on the acute changes in lung function. This adds 
another perspective to the cannon of literature regarding 
nutritional requirements for patients with COPD. 
Study results indicated the oral supplement with an  
energy content of 1036 k J  is preferable when compared 
with an energy load of 2092 kJ. The CHO-rich supplement 
produced optimal effect on lung function and less short- 
ness of breath (SOB), and the high-fat supplement was 
associated with a higher level of dyspnea. According to 
Wilson et  al,' because COPD patients have limited venti- 
latory reserve, it  may be expected tha t  a high CHO diet 
would produce more carbon dioxide (CO,) for each mole of 
0, consumed for energy requirements. The authors in this 
study found that the patients who consumed the CHO rich 
supplement exhibited a higher respiratory quotient due to 
increased carbon dioxide production instead of decreased 
oxygen consumption. They theorize that this may be 
attributed to more efficient metabolism. 
The overall conclusion is that  contrary to current 
beliefs, CHO rich supplements do not have a n  adverse 
effect on acute lung function. In fact, the authors went one 
step further to suggest tha t  similar to the  findings in the  
Sports hledicine literature, high CHO supplenients are 
actually beneficial to lung function. 
One concern, is the ability of practitioners to replicate 
this administration regimen under conditions of normal 
daily clinical practice. I t  is difficult or near impossible to 
administer supplements to a patient in 5 minutes and to 
get them to exercise after 30 minutes. We believe that the 
most important clinical finding of the study is the reduced 
endurance capacity exhibited by patients with decreased 
body mass index when given the nutrient dense formula 
(2092 kJ). Further research is definitely needed on appro- 
priate nutrient requirements of COPD patients with low 
body mass index. I t  also indicatesthat clinicians should be 
cautious with nutrient dense supplementation, and  
should e r r  on the side of standard caloric-balanced sup- 
plements. It i s  our experience that patients with COPD 
respond optimally to supplements or tube feedings with a 
balanced macronutrient profile, compared with supple- 
ments that  provide excessive amount of fat or carbohy- 
drates. 
Edwina Lansangan, hZS, RD, CNSD and 
Jane t  Reid-Hector, hlS, RD, CNSD 
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